Priscilla Kincaid-Smith

Summary

Affiliation: Epworth Hospital
Country: Australia

Publications

  1. ncbi Pharmacological management of membranous nephropathy
    Priscilla Kincaid-Smith
    Epworth Medical Centre, Richmond, and Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia
    Curr Opin Nephrol Hypertens 11:149-54. 2002
  2. ncbi Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
    Priscilla Kincaid-Smith
    Epworth Hospital, Richmond, Victoria, Australia
    Nephrol Dial Transplant 17:597-601. 2002
  3. ncbi Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure
    Priscilla Kincaid-Smith
    Epworth Hospital, Richmond, Victoria, Australia
    Nephrol Dial Transplant 19:2272-4. 2004
  4. ncbi Excitement of research
    Priscilla Kincaid-Smith
    Department of Nephrology, Epworth Hospital, Melbourne, Victoria, Australia
    Intern Med J 34:515-6. 2004
  5. ncbi The investigation of hematuria
    Priscilla Kincaid-Smith
    Epworth Medical Centre, Richmond, Victoria, Australia
    Semin Nephrol 25:127-35. 2005
  6. ncbi Reduction of proteinuria by rosiglitazone in non-diabetic renal disease
    Priscilla Kincaid-Smith
    Epworth Hospital, Department of Pathology, Faculty Education Unit, University of Melbourne, Melbourne, Victoria, Australia
    Nephrology (Carlton) 13:58-62. 2008
  7. ncbi Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'
    Priscilla Kincaid-Smith
    University of Melbourne, Epworth Medical Centre, Richmond, Victoria, Australia
    J Hypertens 22:1051-5. 2004

Detail Information

Publications7

  1. ncbi Pharmacological management of membranous nephropathy
    Priscilla Kincaid-Smith
    Epworth Medical Centre, Richmond, and Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia
    Curr Opin Nephrol Hypertens 11:149-54. 2002
    ....
  2. ncbi Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
    Priscilla Kincaid-Smith
    Epworth Hospital, Richmond, Victoria, Australia
    Nephrol Dial Transplant 17:597-601. 2002
    ....
  3. ncbi Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure
    Priscilla Kincaid-Smith
    Epworth Hospital, Richmond, Victoria, Australia
    Nephrol Dial Transplant 19:2272-4. 2004
    ..This study compares the effect of increasing the ACEI dose by 50% with that of adding an AIIRA to a standard ACEI dose...
  4. ncbi Excitement of research
    Priscilla Kincaid-Smith
    Department of Nephrology, Epworth Hospital, Melbourne, Victoria, Australia
    Intern Med J 34:515-6. 2004
  5. ncbi The investigation of hematuria
    Priscilla Kincaid-Smith
    Epworth Medical Centre, Richmond, Victoria, Australia
    Semin Nephrol 25:127-35. 2005
    ..Thirty percent of patients with isolated microscopic hematuria have mesangial immunoglobulin A glomerulonephritis (IgAN) shown on biopsy examination and 20% to 40% of these patients will progress to renal failure without treatment...
  6. ncbi Reduction of proteinuria by rosiglitazone in non-diabetic renal disease
    Priscilla Kincaid-Smith
    Epworth Hospital, Department of Pathology, Faculty Education Unit, University of Melbourne, Melbourne, Victoria, Australia
    Nephrology (Carlton) 13:58-62. 2008
    ..To investigate the effect of a thiazolidinedione on proteinuria in patients with non-diabetic renal disease...
  7. ncbi Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'
    Priscilla Kincaid-Smith
    University of Melbourne, Epworth Medical Centre, Richmond, Victoria, Australia
    J Hypertens 22:1051-5. 2004
    ....